In October 2020 our new investor Bridgepoint visited the Farmabios site in Gropello-Cairolli (Italy).
Besides holding its regular board meeting, the attendees went on an extensive plant tour. They were impressed by its capabilities, the in-depth know-how of its employees and the rapid progress of the new steroid building construction. The latter is going to support the unabated growth of the Farmabios portfolio in the years to come. Our board also underlined its commitment to support the continued success of Farmabios by agreeing to add-on investments in capabilities and resources.
